“Selection of appropriate diagnostic imaging examinations is a critical step in the diagnostic pathway, however, trainees demonstrate widely variable knowledge of appropriate imaging, particularly pertaining to imaging pregnant patients,” Thaddeus D. Hollingsworth, MD, and colleagues wrote, in a recent study.

A New York City-based medtech startup called Ezra is about to replace pain inducing blood tests and biopsies with MRIs as part of its new prostate cancer screening subscription service, according to a recent report by TechCrunch.

In patients with pathologic pelvic fractures, fluoroscopy and cone-beam CT needle-guided percutaneous screw fixation resulted in short rehabilitation times and reduced opioid use, reported authors of a recent study published in Radiology.

The technology, which combines two imaging modalities—adaptive optics and angiography—could lead to earlier detection of diseases affecting eye tissue, according to research published Nov. 14 in Communications Biology.

The CEO and founder of the Silicon Valley-based imaging startup Openwater, Mary Lou Jepsen, PhD, is leading her company into making portable, miniature medical imaging devices that she hopes will disrupt the MRI market as a more affordable and accurate modality, according to an article published Nov. 13 by Business Insider.

A new class at Penn State College of Medicine in Pennsylvania is helping students identify and prevent systemic causes of misdiagnoses, according to a university news release published Oct. 31.

A score made up of four MRI markers of cerebral small vessel disease (CSVD) has been linked to stroke, dementia and mortality in older adults, reported authors of an Oct. 24 study published in Stroke.

A new study published in Experimental and Therapeutic Medicine found combining a CT scan with pathology results would improve the diagnosis and differential diagnosis of lung ground-glass opacity (GGO).